KDM6B seems to prevent some neurodegenerative diseases, such as Alzheimer’s disease [23], but the most documented disease linked to KDM6B and EZH2 dysregulation is cancer [23,24,25]. This evidence concerns the gene KDM6B and neurodegenerative disease.